These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24450337)

  • 1. 4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide (ML267), a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth.
    Foley TL; Rai G; Yasgar A; Daniel T; Baker HL; Attene-Ramos M; Kosa NM; Leister W; Burkart MD; Jadhav A; Simeonov A; Maloney DJ
    J Med Chem; 2014 Feb; 57(3):1063-78. PubMed ID: 24450337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Chemoproteomics Approach to Investigate Phosphopantetheine Transferase Activity at the Cellular Level.
    Konno S; Ishikawa F; Suzuki T; Dohmae N; Kakeya H; Tanabe G
    Chembiochem; 2017 Sep; 18(18):1855-1862. PubMed ID: 28722191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubility.
    Reck F; Zhou F; Eyermann CJ; Kern G; Carcanague D; Ioannidis G; Illingworth R; Poon G; Gravestock MB
    J Med Chem; 2007 Oct; 50(20):4868-81. PubMed ID: 17722903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphopantetheinyl transferase inhibition and secondary metabolism.
    Foley TL; Young BS; Burkart MD
    FEBS J; 2009 Dec; 276(23):7134-45. PubMed ID: 19895578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy to discover inhibitors of Bacillus subtilis surfactin-type phosphopantetheinyl transferase.
    Yasgar A; Foley TL; Jadhav A; Inglese J; Burkart MD; Simeonov A
    Mol Biosyst; 2010 Feb; 6(2):365-75. PubMed ID: 20094656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antibacterial and anti-MRSA activity, in vivo toxicity and a structure-activity relationship study of a quinoline thiourea.
    Dolan N; Gavin DP; Eshwika A; Kavanagh K; McGinley J; Stephens JC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):630-635. PubMed ID: 26639761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of antibacterial and antibiofilm activities of pyridin-2-yl hexanoate.
    Kouidhi B; Hagar M; Radwan NRE; Chaieb K
    Microb Pathog; 2018 Dec; 125():205-209. PubMed ID: 30219392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent techniques for discovery and characterization of phosphopantetheinyl transferase inhibitors.
    Kosa NM; Foley TL; Burkart MD
    J Antibiot (Tokyo); 2014 Jan; 67(1):113-20. PubMed ID: 24192555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli Nissle 1917 secondary metabolism: aryl polyene biosynthesis and phosphopantetheinyl transferase crosstalk.
    Jones CV; Jarboe BG; Majer HM; Ma AT; Beld J
    Appl Microbiol Biotechnol; 2021 Oct; 105(20):7785-7799. PubMed ID: 34546406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and flexible biochemical assays for evaluating 4'-phosphopantetheinyl transferase activity.
    Owen JG; Copp JN; Ackerley DF
    Biochem J; 2011 Jun; 436(3):709-17. PubMed ID: 21466506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, biochemistry, and inhibition of essential 4'-phosphopantetheinyl transferases from two species of Mycobacteria.
    Vickery CR; Kosa NM; Casavant EP; Duan S; Noel JP; Burkart MD
    ACS Chem Biol; 2014 Sep; 9(9):1939-44. PubMed ID: 24963544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-O chemistry for antibiotics: discovery of N-alkyl-N-(pyridin-2-yl)hydroxylamine scaffolds as selective antibacterial agents using nitroso Diels-Alder and ene chemistry.
    Wencewicz TA; Yang B; Rudloff JR; Oliver AG; Miller MJ
    J Med Chem; 2011 Oct; 54(19):6843-58. PubMed ID: 21859126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
    Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S
    Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
    Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
    Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl urea analogs with broad-spectrum antibacterial activity.
    Seth PP; Ranken R; Robinson DE; Osgood SA; Risen LM; Rodgers EL; Migawa MT; Jefferson EA; Swayze EE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5569-72. PubMed ID: 15482926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene cloning, expression and functional characterization of a phosphopantetheinyl transferase from Vibrio anguillarum serotype O1.
    Liu Q; Ma Y; Zhou L; Zhang Y
    Arch Microbiol; 2005 Jan; 183(1):37-44. PubMed ID: 15551118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.
    Mekky AEM; Sanad SMH
    Bioorg Chem; 2020 Sep; 102():104094. PubMed ID: 32711085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of biological activities of 1,3-oxazolidinone derivatives bearing amide, sulfonamide, and thiourea moieties.
    Karaman N; Adil Zainel R; Kapkaç HA; Karaca Gençer H; Ilgın S; Karaduman AB; Karaküçük-İyidoğan A; Oruç-Emre EE; Koçyiğit-Kaymakçıoğlu B
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800057. PubMed ID: 30079557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Guided In Vitro to In Vivo Pharmacokinetic Optimization of Propargyl-Linked Antifolates.
    Lombardo MN; G-Dayanandan N; Keshipeddy S; Zhou W; Si D; Reeve SM; Alverson J; Barney P; Walker L; Hoody J; Priestley ND; Obach RS; Wright DL
    Drug Metab Dispos; 2019 Sep; 47(9):995-1003. PubMed ID: 31201212
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.